Abstract
Petteri Orpo’s government program plans to reform pharmaceutical and pharmacy regulation in Finland. In this memo, we review some of the effects of cost-saving measures targeted at the pharmaceutical markets in light of recent economic research.
We present two recommendations. First, we propose transferring medicines to the general VAT rate. Secondly, we recommend reforming or replacing the pharmacy tax with the standard corporate tax, should the regulation of pharmacy numbers and locations be removed.
We present two recommendations. First, we propose transferring medicines to the general VAT rate. Secondly, we recommend reforming or replacing the pharmacy tax with the standard corporate tax, should the regulation of pharmacy numbers and locations be removed.
| Translated title of the contribution | Public Finance Perspective from Recent Studies on Finnish Pharmaceutical Markets |
|---|---|
| Original language | Finnish |
| Publisher | Elinkeinoelämän tutkimuslaitos ETLA |
| Number of pages | 10 |
| Publication status | Published - 17 Apr 2025 |
| MoE publication type | D4 Published development or research report or study |
Publication series
| Name | ETLA Muistio |
|---|---|
| No. | 157 |
| ISSN (Electronic) | 2323-2463 |
Fingerprint
Dive into the research topics of 'Public Finance Perspective from Recent Studies on Finnish Pharmaceutical Markets'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver